J-H Fan1, J-B Wang2, C-X Qu1, Y-Q Zhang1, P R Taylor3, C C Abnet4, S M Dawsey4, Y-L Qiao5. 1. Department of Cancer Epidemiology, Cancer Institute/Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. 2. Department of Cancer Epidemiology, Cancer Institute/Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; Department of Epidemiology and Health Statistics, School of Public Health, Zhejiang University, Hangzhou, China. 3. Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, USA. 4. Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, USA. 5. Department of Cancer Epidemiology, Cancer Institute/Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. Electronic address: qiaoy@cicams.ac.cn.
Abstract
BACKGROUND: Oral leukoplakia is a precancerous disorder that is common among residents in Linxian. However, the associations between oral leukoplakia and upper gastrointestinal cancers have not been reported. We investigated the relationships between oral leukoplakia and upper gastrointestinal cancers in the Linxian General Population Trial cohort. METHODS: The Linxian General Population Trial cohort, with 29,584 healthy adults enrolled in 1985 and followed through the end of 2012. With collected baseline data, hazard ratios (HR) and 95% confidence intervals (95% CI) for developing upper gastrointestinal cancers were estimated using Cox proportional hazard models. RESULTS: During 28 years of follow-up, we confirmed a total of 2924 incident esophageal squamous cell carcinoma (ESCC) cases, 1644 gastric cardia cancers and 590 gastric non-cardia cancers. Overall, participants with oral leukoplakia had significantly higher risk of developing ESCC (HR=1.18, 95% CI: 1.08, 1.29). Among individuals ⩽52 years old at baseline, oral leukoplakia was associated with elevated risk of ESCC (HR=1.31, 95%CI: 1.15, 1.49). No significant associations were observed for gastric cardia or non-cardia cancers in either all subjects or subgroups. CONCLUSIONS: Oral leukoplakia was associated with increased risk of ESCC, particularly in younger population. Future studies are needed to confirm these findings.
BACKGROUND:Oral leukoplakia is a precancerous disorder that is common among residents in Linxian. However, the associations between oral leukoplakia and upper gastrointestinal cancers have not been reported. We investigated the relationships between oral leukoplakia and upper gastrointestinal cancers in the Linxian General Population Trial cohort. METHODS: The Linxian General Population Trial cohort, with 29,584 healthy adults enrolled in 1985 and followed through the end of 2012. With collected baseline data, hazard ratios (HR) and 95% confidence intervals (95% CI) for developing upper gastrointestinal cancers were estimated using Cox proportional hazard models. RESULTS: During 28 years of follow-up, we confirmed a total of 2924 incident esophageal squamous cell carcinoma (ESCC) cases, 1644 gastric cardia cancers and 590 gastric non-cardia cancers. Overall, participants with oral leukoplakia had significantly higher risk of developing ESCC (HR=1.18, 95% CI: 1.08, 1.29). Among individuals ⩽52 years old at baseline, oral leukoplakia was associated with elevated risk of ESCC (HR=1.31, 95%CI: 1.15, 1.49). No significant associations were observed for gastric cardia or non-cardia cancers in either all subjects or subgroups. CONCLUSIONS:Oral leukoplakia was associated with increased risk of ESCC, particularly in younger population. Future studies are needed to confirm these findings.
Authors: Behnoush Abedi-Ardekani; Farin Kamangar; Stephen M Hewitt; Pierre Hainaut; Masoud Sotoudeh; Christian C Abnet; Philip R Taylor; Paolo Boffetta; Reza Malekzadeh; Sanford M Dawsey Journal: Gut Date: 2010-06-28 Impact factor: 23.059
Authors: P Limburg; Y Qiao; S Mark; G Wang; G Perez-Perez; M Blaser; Y Wu; X Zou; Z Dong; P Taylor; S Dawsey Journal: J Natl Cancer Inst Date: 2001-02-07 Impact factor: 13.506
Authors: S D Mark; Y L Qiao; S M Dawsey; Y P Wu; H Katki; E W Gunter; J F Fraumeni; W J Blot; Z W Dong; P R Taylor Journal: J Natl Cancer Inst Date: 2000-11-01 Impact factor: 13.506
Authors: Jacques Ferlay; Hai-Rim Shin; Freddie Bray; David Forman; Colin Mathers; Donald Maxwell Parkin Journal: Int J Cancer Date: 2010-12-15 Impact factor: 7.396
Authors: M Hashibe; R Sankaranarayanan; G Thomas; B Kuruvilla; B Mathew; T Somanathan; D M Parkin; Z F Zhang Journal: Int J Cancer Date: 2000-10-01 Impact factor: 7.396
Authors: Christian C Abnet; Neal D Freedman; Nan Hu; Zhaoming Wang; Kai Yu; Xiao-Ou Shu; Jian-Min Yuan; Wei Zheng; Sanford M Dawsey; Linda M Dong; Maxwell P Lee; Ti Ding; You-Lin Qiao; Yu-Tang Gao; Woon-Puay Koh; Yong-Bing Xiang; Ze-Zhong Tang; Jin-Hu Fan; Chaoyu Wang; William Wheeler; Mitchell H Gail; Meredith Yeager; Jeff Yuenger; Amy Hutchinson; Kevin B Jacobs; Carol A Giffen; Laurie Burdett; Joseph F Fraumeni; Margaret A Tucker; Wong-Ho Chow; Alisa M Goldstein; Stephen J Chanock; Philip R Taylor Journal: Nat Genet Date: 2010-08-22 Impact factor: 38.330
Authors: He Liang; Zhao Yang; Jian-Bing Wang; Pei Yu; Jin-Hu Fan; You-Lin Qiao; Philip R Taylor Journal: Thorac Cancer Date: 2017-09-20 Impact factor: 3.500
Authors: Jin-Hu Fan; Jian-Bing Wang; Shao-Ming Wang; Christian C Abnet; You-Lin Qiao; Philip R Taylor Journal: Cancer Sci Date: 2017-06-30 Impact factor: 6.716